Schedule 13D ownership disclosure

ACADIA Pharmaceuticals Inc

Security class unavailable · CUSIP: 004225108

Event date: 2023-05-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
43,084,280
Percent of class
26.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-064183
Form type
SC 13D/A
Filer
ACADIA PHARMACEUTICALS INC
CIK
CIK 1070494
Filed
May 24, 2023
Reporting period
May 23, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub